Centene (CNC) Revenue & Revenue Breakdown
Centene Revenue Highlights
Latest Revenue (Y)
$163.07B
Latest Revenue (Q)
$48.74B
Main Segment (Y)
Medicaid Segment
Centene Revenue by Period
Centene Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $163.07B | 5.89% |
| 2023-12-31 | $154.00B | 6.54% |
| 2022-12-31 | $144.55B | 14.74% |
| 2021-12-31 | $125.98B | 13.38% |
| 2020-12-31 | $111.11B | 48.87% |
| 2019-12-31 | $74.64B | 24.16% |
| 2018-12-31 | $60.12B | 24.25% |
| 2017-12-31 | $48.38B | 19.15% |
| 2016-12-31 | $40.61B | 78.41% |
| 2015-12-31 | $22.76B | 37.44% |
| 2014-12-31 | $16.56B | 52.44% |
| 2013-12-31 | $10.86B | 25.33% |
| 2012-12-31 | $8.67B | 62.30% |
| 2011-12-31 | $5.34B | 20.06% |
| 2010-12-31 | $4.45B | 8.42% |
| 2009-12-31 | $4.10B | 21.95% |
| 2008-12-31 | $3.36B | 15.25% |
| 2007-12-31 | $2.92B | 28.09% |
| 2006-12-31 | $2.28B | 51.34% |
| 2005-12-31 | $1.51B | 50.44% |
| 2004-12-31 | $1.00B | 30.04% |
| 2003-12-31 | $769.73M | 66.79% |
| 2002-12-31 | $461.49M | 41.31% |
| 2001-12-31 | $326.57M | 47.54% |
| 2000-12-31 | $221.35M | 9.89% |
| 1999-12-31 | $201.43M | - |
Centene generated $163.07B in revenue during NA 2024, up 5.89% compared to the previous quarter, and up 218.48% compared to the same period a year ago.
Centene Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $48.74B | 4.55% |
| 2025-03-31 | $46.62B | 14.25% |
| 2024-12-31 | $40.80B | -2.90% |
| 2024-09-30 | $42.02B | 5.49% |
| 2024-06-30 | $39.84B | -1.41% |
| 2024-03-31 | $40.41B | 2.40% |
| 2023-12-31 | $39.46B | 3.73% |
| 2023-09-30 | $38.04B | 1.15% |
| 2023-06-30 | $37.61B | -3.29% |
| 2023-03-31 | $38.89B | 9.36% |
| 2022-12-31 | $35.56B | -0.85% |
| 2022-09-30 | $35.87B | -0.20% |
| 2022-06-30 | $35.94B | -3.36% |
| 2022-03-31 | $37.19B | 14.18% |
| 2021-12-31 | $32.57B | 0.50% |
| 2021-09-30 | $32.41B | 4.45% |
| 2021-06-30 | $31.02B | 3.48% |
| 2021-03-31 | $29.98B | 5.99% |
| 2020-12-31 | $28.29B | -2.76% |
| 2020-09-30 | $29.09B | 4.97% |
| 2020-06-30 | $27.71B | 6.48% |
| 2020-03-31 | $26.02B | 37.97% |
| 2019-12-31 | $18.86B | -0.60% |
| 2019-09-30 | $18.98B | 3.38% |
| 2019-06-30 | $18.36B | -0.48% |
| 2019-03-31 | $18.44B | 11.38% |
| 2018-12-31 | $16.56B | 2.33% |
| 2018-09-30 | $16.18B | 14.11% |
| 2018-06-30 | $14.18B | 7.48% |
| 2018-03-31 | $13.19B | 3.03% |
| 2017-12-31 | $12.81B | 7.63% |
| 2017-09-30 | $11.90B | -0.47% |
| 2017-06-30 | $11.95B | 1.96% |
| 2017-03-31 | $11.72B | -1.57% |
| 2016-12-31 | $11.91B | 9.82% |
| 2016-09-30 | $10.85B | -0.47% |
| 2016-06-30 | $10.90B | 56.72% |
| 2016-03-31 | $6.95B | 10.33% |
| 2015-12-31 | $6.30B | 8.26% |
| 2015-09-30 | $5.82B | 5.72% |
| 2015-06-30 | $5.51B | 7.31% |
| 2015-03-31 | $5.13B | 8.60% |
| 2014-12-31 | $4.72B | 8.56% |
| 2014-09-30 | $4.35B | 8.16% |
| 2014-06-30 | $4.02B | 16.30% |
| 2014-03-31 | $3.46B | 28.72% |
| 2013-12-31 | $2.69B | -4.13% |
| 2013-09-30 | $2.80B | 2.85% |
| 2013-06-30 | $2.73B | 3.03% |
| 2013-03-31 | $2.65B | 10.40% |
| 2012-12-31 | $2.40B | -2.10% |
| 2012-09-30 | $2.45B | 15.98% |
| 2012-06-30 | $2.11B | 23.28% |
| 2012-03-31 | $1.71B | 13.60% |
| 2011-12-31 | $1.51B | 15.76% |
| 2011-09-30 | $1.30B | -0.99% |
| 2011-06-30 | $1.32B | 8.11% |
| 2011-03-31 | $1.22B | 3.00% |
| 2010-12-31 | $1.18B | 5.27% |
| 2010-09-30 | $1.12B | 4.19% |
| 2010-06-30 | $1.08B | 0.75% |
| 2010-03-31 | $1.07B | -2.20% |
| 2009-12-31 | $1.09B | 5.25% |
| 2009-09-30 | $1.04B | -0.12% |
| 2009-06-30 | $1.04B | 11.48% |
| 2009-03-31 | $932.43M | 17.93% |
| 2008-12-31 | $790.67M | -11.87% |
| 2008-09-30 | $897.14M | 4.31% |
| 2008-06-30 | $860.07M | 5.32% |
| 2008-03-31 | $816.64M | - |
Centene generated $48.74B in revenue during Q2 2025, up 4.55% compared to the previous quarter, and up 120.63% compared to the same period a year ago.
Centene Revenue Breakdown
Centene Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Other Operating Segment | $4.92B | - | - | - | - |
| Commercial Segment | $33.70B | - | - | - | - |
| Medicaid Segment | $124.45B | - | - | - | - |
| Health Care, Premium | - | $135.64B | $127.13B | $112.32B | $100.06B |
| Service | - | $4.46B | $8.35B | $5.66B | $3.75B |
Latest
Centene's latest annual revenue breakdown by segment (product or service), as of Dec 24: Medicaid Segment (76.32%), Commercial Segment (20.67%), and Other Operating Segment (3.02%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicaid Segment | $37.45B | $35.19B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Segment | $1.22B | $1.28B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Commercial Segment | $10.07B | $10.15B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Specialty Services | - | - | $784.00M | $833.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Managed Care | - | - | $36.12B | $35.14B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Service | - | - | - | - | $1.11B | $1.10B | $1.13B | $1.13B | $1.67B | $1.88B | $2.46B | $2.34B | $1.61B | $1.64B | $1.24B | $1.18B | $886.00M | $922.00M | $979.00M | $958.00M |
| Health Care, Premium | - | - | - | - | $101.77B | $33.87B | $31.88B | $31.85B | $31.51B | $31.89B | $28.88B | $28.88B | $27.63B | $26.93B | $25.56B | $26.54B | $24.75B | $23.21B | - | - |
Latest
Centene's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Medicaid Segment (76.83%), Commercial Segment (20.66%), and Other Operating Segment (2.51%).
Centene Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CNC | Centene | $163.07B | $48.74B |
| MOH | Molina Healthcare | $40.65B | $20.99B |
| THC | Tenet Healthcare | $20.66B | $5.29B |
| FMS | Fresenius Medical Care AG & Co. KGaA | $19.45B | $4.72B |
| UHS | Universal Health Services | $15.83B | $4.28B |
| ILMN | Illumina | $4.37B | $1.06B |
| INCY | Incyte | $4.24B | $1.37B |
| WAT | Waters | $2.96B | $771.33M |
| WST | West Pharmaceutical Services | $2.89B | $804.70M |
| UTHR | United Therapeutics | $2.88B | $798.60M |
| ZBH | Zimmer Biomet | $2.02B | - |